Author:
Tasaka K.,Hamada M.,Mio M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Toxicology,Pharmacology,Immunology
Reference5 articles.
1. E. Schmitt, B. Fassbender, K. Beyreuther, E. Spaeth, R. Schwarzkopf and E. Ruede,Characterization of a T cell-derived lymphokine that acts synergistically with IL-3 on the growth of murine mast cells and is identical with IL-4. Immunobiol.174, 406–419 (1987).
2. L. Hultner, C. Druez, J. Moeller, C. Uyttenhove, E. Schmitt, E. Rude, P. Dormer and J. Van Snick,Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur. J. Immunol.20, 1413–1416 (1990).
3. A. W. Massey, C. T. Randall, J. A. Kagey, M. S. MacDonald, S. Gillis, C. A. Allison and L. M. Lichtenstein,Recombinant human IL-1α and-1β potential IgE-mediated histamine release from human basophils. J. Immunol.143, 1875–1880 (1989).
4. M. Haak-Frendscho, N. Arai and K. Arai,Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin-3 cause basophil histamine release. J. Clin. Invest.82, 17–20 (1988).
5. K. Machoczek, M. Fischer and H.-D. Soling,Lipocortin I and lipocortin II inhibit phosphoinositide- and polyphosphoinositide-specific phospholipase C. The effect results from interaction with the substrates. FEBS Lett.251, 207–212 (1989).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献